Dna Repair Mechanisms In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
DNA damage accumulates in neurons over time due to oxidative stress, metabolic byproducts, and environmental factors. Efficient DNA repair is crucial for neuronal survival, as post-mitotic neurons cannot dilute damage through cell division. Impaired DNA repair mechanisms contribute to neurodegeneration in multiple diseases.
The cell employs multiple DNA repair pathways, each handling specific types of damage:
| Pathway |
Damage Type |
Key Proteins |
| Base Excision Repair (BER) |
Oxidative damage, small alkylations |
OGG1, PARP1, XRCC1, Pol β |
| Nucleotide Excision Repair (NER) |
UV damage, bulky adducts |
XPA-XPG, TFIIH, CSA/CSB |
| Mismatch Repair (MMR) |
Replication errors |
MSH2, MSH6, MLH1, PMS2 |
| Double-Strand Break Repair (DSBR) |
DSBs, radiation |
BRCA1, ATM, ATR, XRCC4, Ligase IV |
| Non-Homologous End Joining (NHEJ) |
DSBs |
Ku70/80, DNA-PKcs (PRKDC), XRCC4, POLM |
| Homologous Recombination (HR) |
DSBs, replication forks |
RAD51, BRCA1/2, RPA |
- Oxidative stress — ROS from mitochondrial metabolism cause 8-oxoguanine lesions
- Mitochondrial dysfunction — impaired electron transport increases ROS
- Neuroinflammation — activated microglia produce reactive species
- Environmental toxins — pesticides, metals can cause direct damage
- Normal metabolism — spontaneous deamination, depurination
- Long lifespan requires lifetime DNA maintenance
- High metabolic rate produces constant oxidative burden
- Limited regenerative capacity means damaged neurons must be preserved
- Chromatin remodeling required for repair access
DNA repair capacity declines in Alzheimer's disease:
- Reduced BER activity — OGG1 and Pol β activity decreased
- Accumulation of 8-oxoguanine — oxidative lesions build up
- NER impairment — XPA and XPC levels reduced
- Chromatin relaxation defects — impaired access to damaged DNA
- APOE — ε4 allele associated with reduced DNA repair
- TREM2 — microglial DNA repair affects inflammation
- OTS1 — oxidative DNA damage response
- Poly(ADP-ribose) polymerase (PARP) inhibitors under investigation
- Antioxidant therapies to reduce oxidative DNA damage
- Gene therapy approaches for DNA repair enzymes
Parkinson's disease shows prominent mitochondrial DNA damage:
- mtDNA deletions — accumulate in substantia nigra neurons
- Complex I deficiency — increases oxidative stress
- PINK1 and PARK7 — involved in mitochondrial DNA quality control
- LRRK2 — regulates DNA damage response
- Impaired BER pathway
- Increased sensitivity to genotoxic stress
- PARP1 activation in affected neurons
Huntington's disease shows unique DNA repair involvement:
- Somatic CAG expansion — varies by tissue, most dramatic in neurons
- DNA repair gene modifiers — MSH3, FAN1, RRM2B affect onset
- Base excision repair role — OGG1 promotes repeat expansion
- MSH3 knockout — reduces somatic expansion, delays onset
- DNA repair pathway genes modify age of onset
- MSH3 — major modifier locus
- FAN1 — nuclease involved in repair
ALS shows significant oxidative DNA damage:
- SOD1 mutations — produce oxidative stress
- C9orf72 — RNA foci may interfere with DNA repair
- FUS — involved in DNA damage response
- TARDBP — TDP-43 pathology affects repair genes
- PARP inhibitors under investigation
- Antioxidant therapies
- Gene therapy for DNA repair proteins
¶ DNA Repair in Aging and neurodegeneration
DNA repair capacity naturally declines with age:
- Reduced repair enzyme expression
- Decreased NAD+ levels — affects PARP activity
- Senescence-associated DNA damage
- Telomere attrition
¶ NAD+ and DNA Repair
- NAD+ is essential for PARP function
- NAD+ depletion impairs DNA repair
- NAD+ precursors (NR, NMN) being studied
| Target |
Strategy |
Status |
| PARP |
Inhibitors |
Clinical trials |
| NAD+ precursors |
NMN, NR supplementation |
Preclinical/clinical |
| OGG1 |
Activity enhancers |
Preclinical |
| ATM/ATR |
Kinase inhibitors |
Investigational |
- Caloric restriction — enhances DNA repair
- Exercise — reduces oxidative DNA damage
- Antioxidant-rich diet
The study of Dna Repair Mechanisms In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Madabhushi et al., Activity-Induced DNA Breaks Shape Neuronal Chromatin (2014)
- Kelley et al., DNA repair in the aging brain (2014)
- Swanson et al., DNA repair in Huntington's disease (2021)
- Kim et al., DNA damage in neurodegenerative diseases (2022)
- Hou et al., NAD+ metabolism in brain aging and neurodegeneration (2022)